Advertisement

Overview of Tuberculosis

  • Wei-ye Yu
  • Yun-xia Wang
  • Jin-zhou Mei
  • Fang-xiang Hu
  • Le-cai Ji
Chapter

Abstract

Tuberculosis (TB) is a chronic infectious disease caused by the infection of Mycobacterium tuberculosis (Mtb) which spreads via respiratory tract. Lungs are the most commonly infected human organ whose infection accounts for above 80% of tuberculosis. Therefore, TB is also known as pulmonary TB [1]. There had been a long history of TB before its pathogenesis, spreading routes, treatment, and prevention of TB have been elucidated.

References

  1. 1.
    Wang, C. Screening for biological markers specific to pulmonary tuberculosis and identification of genes responsible for its susceptibility. Zhejiang University, 2016.Google Scholar
  2. 2.
    Niemi R. A brief history of Mycobacterium tuberculosis’ Etiology. [2018-11-9]. http://www.intellectualventureslab.com/invent/brief-mtb-history.
  3. 3.
    He GX, Wang LX. Evolution of strategies for tuberculosis control. Forum Prev Med. 2008;14(6):481–4.Google Scholar
  4. 4.
    World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report 2006. Geneva: World Health Organization; 2006.Google Scholar
  5. 5.
    World Health Organization. Drug-resistant TB: surveillance & response: supplement to the global tuberculosis report 2014. Geneva: World Health Organization; 2014.Google Scholar
  6. 6.
    World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization; 2018.Google Scholar
  7. 7.
    World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization; 2017.Google Scholar
  8. 8.
    Tiemersma EW, Van Der Werf MJ, Borgdorff MW, et al. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One. 2011;6(4):e17601.CrossRefGoogle Scholar
  9. 9.
    World Health Organization. Tuberculosis: fact sheet. [2018-11-9]. http://www.who.int/mediacentre/factsheets/fs104/en/.
  10. 10.
    Wang LX, Cheng SM, Chen MT, et al. Report of the 5th national epidemiological sampling survey for tuberculosis in 2010. Chin J Anti-tuberc. 2012;8:485–508.Google Scholar
  11. 11.
    Technique Guidance Team of the National Epidemiological Sampling Survey for Tuberculosis. Report of the 4th national epidemiological sampling survey for tuberculosis. Chin J Tuberc Respir. 2002;1:6–10.Google Scholar
  12. 12.
    Duanmu HJ, Liu YX, Shi HS, et al. Data analysis of the 3rd national epidemiological sampling survey for tuberculosis. Dis Surv. 1995;7:215–7.Google Scholar
  13. 13.
    Leaders Team of the National Epidemiological Sampling Survey for Tuberculosis. Comprehensive brief of the national epidemiological sampling survey for tuberculosis in 1979. Chin J Anti-tuberc Commun. 1982;2:3–6.Google Scholar
  14. 14.
    Kan GQ, Zhang LX. Implications of the 2nd national epidemiological sampling survey for tuberculosis. Chin J Anti-tuberc Commun. 1989;3:97–101.Google Scholar
  15. 15.
    Song WH. Global emergency of tuberculosis and the control of TB in China. Chin J Epidemiol. 1997;18(2):109–11.Google Scholar
  16. 16.
    Liu YH, Jiang GL, Zhao LP, et al. The 4th national epidemiological sampling survey: analysis of drug resistance by Mycobacterium tuberculosis. Chin J Tuberc Respir. 2002;4:32–5.Google Scholar
  17. 17.
    Wang SF, Zhao B, Song YY, et al. The risk factors of drug resistant tuberculosis in China: data analysis of the national baseline survey for drug resistant tuberculosis in 2007. Chin J Anti-tuberc. 2013;4:221–6.Google Scholar
  18. 18.
    The Technique Guidance Team of the National Epidemiological Sampling Survey for Tuberculosis. Report of the national epidemiological sampling survey in 2000. Chin J Anti-tuberc. 2002;2:3–46.Google Scholar
  19. 19.
    Shen X, Song SC, Lei SG. Prevalence and control strategy for drug resistant tuberculosis. Occup Health. 2017;4:566–8.Google Scholar
  20. 20.
    Cheng SM. Current control of multidrug resistant tuberculosis and recommendations. Chin J Trop Med. 2017;3:213–5.Google Scholar
  21. 21.
    General Office of State Council, P. R. China. The national 13th five-year plan for prevention and treatment of tuberculosis. http://www.nhfpc.gov.cn/bgt/gwywj2/201702/7b2a362da2da4841a362f8eb36575b67.shtml.
  22. 22.
    Interpretation of the 2015 world tuberculosis report: evolution of control strategies for tuberculosis. http://www.chinatb.org/kxyj/gjkydt/201602/t20160223_125564.htm.
  23. 23.
    Implementing the End TB strategy: the essentials. http://www.who.int/tb/publications/2015/end_tb_essential.pdf?ua=1.
  24. 24.
    The First Global Ministerial Conference of World Health Organization. http://www.who.int/tb/endtb-sdg-ministerial-conference/zh/.
  25. 25.
    Li L, Liu YH, Ma Y, et al. Evolution of the service system for prevention and treatment of tuberculosis in China and its implications. Chin J Anti-tuberc. 2016;38(11):904–7.Google Scholar
  26. 26.
    Gao JH, Cen ZY, Tan YQ. Development in screening and control of tuberculosis in high-risk populations in China. J Youjiang Med. 2016;44(1):105–8.Google Scholar
  27. 27.
    National Anti-tuberculosis Association of China. Standard procedures in the bacteriological diagnosis of tuberculosis. Chin J Anti-tuberc. 1996;18:28–31.Google Scholar
  28. 28.
    Pan YX, Wu W. Molecular markers for bacteriological surveillance during treatment of tuberculosis. Chin J Tuberc Respir. 2001;24:393–5.Google Scholar
  29. 29.
    Chen XY. Research progress of tuberculosis diagnosis. Chin J Clin. 2013;41(3):11–4.Google Scholar
  30. 30.
    Zhang TM. Sub-clinical tuberculous sepsis. Chin J Tuberc Respir. 2001;24:622–4.Google Scholar
  31. 31.
    Mithison DA. The action of antituberculosis drug in short-course chemotherapy. Tubercle. 1985;66:219–25.CrossRefGoogle Scholar
  32. 32.
    Van Grietnuysen AJ, JaMorgan MA, Horstmeier CD, et al. Comparison of a radiometric method (bactec) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microb. 1983;18:384–8.Google Scholar
  33. 33.
    Nsz AR, Buiting AGM. Comparison of fluorescent Bactec 9000MB system, Septi Check AFB system and LowersteinJensen medium for detection of mycobacteria. J Clin Microb. 1996;34:2391–4.Google Scholar
  34. 34.
    Chen XY, Wang HP, Jin YS, et al. Detection of Mycobacterium tuberculosis DNA by Taqman PCR and its clinical application. Chin J Tuberc Respir. 2000;23(5):284–8.Google Scholar
  35. 35.
    Han XQ, Ma Y, Gao WW, et al. Detection of drug resistant Mycobacterium tuberculosis by bacteriophage biological amplification, DNA sequence analysis and single-strand conformation polymorphism analysis. Chin J Tuberc Respir. 2004;27:815–9.Google Scholar
  36. 36.
    Hu ZY, Ni LD, Jin AJ, et al. Methodological study on rapid detection of Mycobacterium tuberculosis by bacteriophage biological amplification. Chin J Tuberc Respir. 2004;27:801–5.Google Scholar
  37. 37.
    Xie LMY, Gao WW, et al. Significance of interferon-γ release from mononuclear cells of peripheral blood after antigen stimulation in the diagnosis of Mycobacterium tuberculosis infection. Chin J Tuberc Respir. 2005;28:545–9.Google Scholar
  38. 38.
    Aubert-Pivert EM, Chedeverge FM, Lopez-Ramirez GM, et al. Cytokine transcripts in pediatric tuberculosis: a study with bronchoalveolar cells. Tuber Lung Dis. 2000;80:249–58.CrossRefGoogle Scholar
  39. 39.
    Campos-Neto A, Rodrigues-Junior V, Pedral-Samparo DB, et al. Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux test. Tuberculosis. 2001;81(5-6):353–8.CrossRefGoogle Scholar
  40. 40.
    David ST, Mukunkan U, Brahmadath KW, et al. Detecting mycobacterium for diagnosing tuberculosis. Indian J Med Res. 2004;119:259–66.PubMedGoogle Scholar
  41. 41.
    Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003;361:1168–73.CrossRefGoogle Scholar
  42. 42.
    Houghton RL, Lodes M, Dillon DC, et al. Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. Clin Diagn Lab Immunol. 2000;9:883–91.Google Scholar

Copyright information

© People's Medical Publishing House, PR of China 2020

Authors and Affiliations

  • Wei-ye Yu
    • 1
  • Yun-xia Wang
    • 2
  • Jin-zhou Mei
    • 2
  • Fang-xiang Hu
    • 2
  • Le-cai Ji
    • 3
  1. 1.Department of TuberculosisThe Shenzhen Center for Chronic Disease ControlShenzhenChina
  2. 2.Baoan Chronic Diseases Prevent and Cure HospitalShenzhenChina
  3. 3.Shenzhen Center for Chronic Disease ControlShenzhenChina

Personalised recommendations